InvestorsHub Logo
icon url

couldbebetter

12/18/19 9:08 AM

#235497 RE: HDGabor #235488

Thank You! (I appreciate your rational and well reasoned approach
that you take in all of your comments.)
icon url

KCSVEN

12/18/19 9:15 AM

#235502 RE: HDGabor #235488

No way BP prices 50% more for Rest of the world where Amarin has to sell the rights to others and only collect a small percentage in residual. Europe accounted for less than 15% of overall sales for best selling statin without having to be a residual, no way Amarin gets more than 10-15% from a BP for ROW.

I believe that note is unrelated to BO, that note is related to GIA revenue not model for BO In think.

$40 is the low and $55 is high per share in any BO scenario int he next 6 months.